LexIA

Aviso: esto no es asesoría legal. LexIA solo organiza fuentes públicas y puede estar incompleto.

U.S. Code · Título 21

Clinical trial guidance for antibiotic drugs

21 U.S.C. § 360a

Office of the Law Revision Counsel · release 119-142

Texto oficial en GovInfo

Se muestra el texto operativo de la sección. Las notas estatutarias y el historial de enmiendas están en la fuente oficial.

Capítulo 9

(a)

In general

Not later than 1 year after September 27, 2007, the Secretary shall issue guidance for the conduct of clinical trials with respect to antibiotic drugs, including antimicrobials to treat acute bacterial sinusitis, acute bacterial otitis media, and acute bacterial exacerbation of chronic bronchitis. Such guidance shall indicate the appropriate models and valid surrogate markers.

(b)

Review

Not later than 5 years after September 27, 2007, the Secretary shall review and update the guidance described under subsection (a) to reflect developments in scientific and medical information and technology.

(June 25, 1938, ch. 675, § 511, as added Pub. L. 110–85, title IX, § 911, Sept. 27, 2007, 121 Stat. 951.)